+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Protein Engineering for Therapeutics, Part A. Methods in Enzymology Volume 502

  • Book

  • February 2012
  • Elsevier Science and Technology
  • ID: 2237741

This volume of Methods in Enzymology looks at Protein Engineering for Therapeutics. The chapters provide an invaluable resource for academics, researchers and students alike. With an international board of authors, this volume is split into sections that cover subjects such as Antibodies, Protein conjugates, Peptides, Enzymes and Scaffolds

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

  1. Simplified Synthetic Antibody Libraries

  2. Generation of Dual Variable Domain Immunoglobulin Molecules for Dual-specific Targeting

  3. Discovery of internalizing antibodies to tumor antigens from phage libraries

  4. Optimizing properties of anti-receptor antibodies using kinetic computational models and experiments

  5. Cell-specific siRNA delivery by peptides and antibodies

  6. Conjugation of Anticancer Drugs Through Endogenous Monoclonal Antibody Cysteine Residues

  7. Building and characterizing antibody-targeted lipidic nanotherapeutics

  8. Cell-Targeting Fusion Constructs Containing Recombinant Gelonin

  9. Stapled Peptides for Intracellular Drug Targets

  10. Mapping of vascular zip codes by phage display

  11. Engineering cyclic peptide toxins

  12. Peptide Discovery using Bacterial Display and Flow Cytometry

  13. Oral enzyme therapy for celiac sprue

  14. Rational Design and Evaluation of Mammalian Ribonuclease Cytotoxins

  15. Engineering Reduced-Immunogenicity Enzymes for Amino Acid Depletion Therapy in Cancer

  16. Designed Ankyrin Repeat Proteins (DARPins): From research to therapy

  17. Target-binding proteins based on the tenth human fibronectin type III domain (10Fn3)

  18. Anticalins: small engineered binding proteins based on the lipocalin scaffold

  19. T Cell Receptor Engineering

  20. Engineering Knottins as Novel Binding Agents

  21. Re-Engineering Biopharmaceuticals for Targeted Delivery Across the Blood-Brain Barrier

  22. Practical Theoretic Guidance for the Design of Tumor Targeting Agents

  23. Fusions of elastin-like polypeptides to pharmaceutical proteins

  24. Engineering and Identifying Supercharged Proteins for Macromolecule Delivery into Mammalian Cells